Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-17

Clinical Trial Update: F 18 T807 Tau PET Imaging of Alzheimer's Disease

View source ↗

Summary

This clinical trial update describes a study using the F-18 tau PET tracer T807 (flortaucipir) to image tau pathology in Alzheimer's disease. The study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flortaucipir (F-18 T807) Tau PET tracer (flortaucipir)

Snippet

Sponsor: Tammie L. S. Benzinger, MD, PhD | Conditions: Alzheimer Disease | Status: RECRUITING